These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10954)

  • 1. Closing remarks: current status of labetalol.
    Dollery CT
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):823-4. PubMed ID: 10954
    [No Abstract]   [Full Text] [Related]  

  • 2. Labetalol in hypertension.
    Lancet; 1977 May; 1(8022):1147-8. PubMed ID: 68239
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interaction of labetalol with alpha- and beta-adrenergic receptors : biochemical study (author's transl)].
    Dausse JP; Guicheney P; Maich PJ; Meyer P
    Nouv Presse Med; 1978 Oct; 7(35):3121-3. PubMed ID: 31601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Labetalol (Trandate). an antihypertensive agent with both alpha and beta receptor blockading effects].
    Rasmussen S; Andreasen PB
    Ugeskr Laeger; 1980 Mar; 142(13):839-41. PubMed ID: 6102812
    [No Abstract]   [Full Text] [Related]  

  • 5. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
    Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
    Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
    [No Abstract]   [Full Text] [Related]  

  • 6. Some complementary data on AH 5158, an inhibitor of both alpha-and beta-adrenoceptors [proceedings].
    Harichaux P; Hary L
    Br J Pharmacol; 1976 Nov; 58(3):412P. PubMed ID: 11020
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacology of labetalol.
    Richards DA; Prichard BN
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-93S. PubMed ID: 43165
    [No Abstract]   [Full Text] [Related]  

  • 8. Labetolol--combined alpha and beta blockade for hypertension.
    Raftery EB
    Scott Med J; 1978 Oct; 23(4):279-80. PubMed ID: 31683
    [No Abstract]   [Full Text] [Related]  

  • 9. Labetalol for hypertension.
    Drug Ther Bull; 1978 Nov; 16(23):89-90. PubMed ID: 699758
    [No Abstract]   [Full Text] [Related]  

  • 10. Labetalol for hypertension.
    Med Lett Drugs Ther; 1984 Sep; 26(670):83-5. PubMed ID: 6147747
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent.
    Blakeley AG; Summers RJ
    Gen Pharmacol; 1978; 9(6):399-402. PubMed ID: 32121
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-hypertensive action, time of onset and effects on carbohydrate metabolism of labetalol.
    Andersson O; Berglund G; Hansson L
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):757-61. PubMed ID: 1032990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
    Hansson L; Hänel B
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):195-8. PubMed ID: 12115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular effects in normal rabbits of topically applied labetalol: a combined alpha- and beta-adrenergic antagonist.
    Murray DL; Podos SM; Wei C; Leopold IH
    Arch Ophthalmol; 1979 Apr; 97(4):723-6. PubMed ID: 426692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].
    Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P
    Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol: an alpha- and beta-adrenergic receptor blocker.
    Pepper GA
    Nurse Pract; 1985 Jul; 10(7):39-40, 43, 48. PubMed ID: 3855235
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
    Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
    J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol as a hypotensive agent in otological operations.
    Pakkanen A; Kanto J
    Ann Chir Gynaecol; 1979; 68(2):82-3. PubMed ID: 41475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.